Research use only
Lyophilized powder
≥99% purity specification
Bibliographic references on every product page
In-vitro laboratory research
Multi-use vials
Sourced primary literature
Catalog of seventeen compounds
Research use only
Lyophilized powder
≥99% purity specification
Bibliographic references on every product page
In-vitro laboratory research
Multi-use vials
Sourced primary literature
Catalog of seventeen compounds

Research Compounds · Sourced and Referenced

Research
compounds.
Sourced and referenced.

Every compound in our catalog is listed with peer-reviewed references to the primary literature describing the molecule. Sold as research-grade compounds for in-vitro laboratory use.

Biovexia Labs DSIP 5 Lyophilized Powder Multi Use Vial RESEARCH USE ONLY. NOT FOR HUMAN USE.
Biovexia Labs Glutathione Lyophilized Powder Multi Use Vial RESEARCH USE ONLY. NOT FOR HUMAN USE.
Biovexia Labs NAD+ 1000 Lyophilized Powder Multi Use Vial RESEARCH USE ONLY. NOT FOR HUMAN USE.
Biovexia Labs GHK-CU 100 Lyophilized Powder Multi Use Vial RESEARCH USE ONLY. NOT FOR HUMAN USE.

≥99% Purity Specification
Lyophilized Powder
Multi-Use Vials
Peer-Reviewed References
Wyoming-Registered Supplier
Research Use Framework

Research Catalog

Research compounds.
Sourced and cataloged.

View All →

BL Blend 2

Peptide Blend
BL Blend 2
GHK-Cu / BPC-157 / TB-500
Three-component peptide blend: GHK-Cu (tripeptide-copper complex), BPC-157 (15-residue gastric pentadecapeptide), and TB-500 (43-residue thymosin β4 fragment). Single-vial lyophilized preparation.

View Studies →

Purity≥99%
FormLyophilized
Storage−20°C
VialMulti-use

Glutathione

Tripeptide
Glutathione
γ-Glu-Cys-Gly · GSH
Endogenous tripeptide composed of glutamate, cysteine, and glycine, with a γ-peptide bond between glutamate and cysteine. C₁₀H₁₇N₃O₆S, MW 307.32, CAS 70-18-8.
Purity≥99%
FormLyophilized
Storage−20°C
VialMulti-use

NAD+

Pyridine Dinucleotide
NAD+
Nicotinamide Adenine Dinucleotide
Pyridine dinucleotide composed of nicotinamide and adenine ribonucleotides joined by a pyrophosphate linkage. C₂₁H₂₇N₇O₁₄P₂, MW 663.43, CAS 53-84-9.

View Studies →

Purity≥99%
FormLyophilized
Storage−20°C
VialMulti-use

BPC-157

Gastric Pentadecapeptide
BPC-157
Body Protection Compound-157
Synthetic 15-residue peptide. Sequence GEPPPGKPADDAGLV. C₆₂H₉₈N₁₆O₂₂, MW 1419.53, CAS 137525-51-0. Partial sequence derived from human gastric juice protein BPC.

View Studies →

BL Blend 1

Peptide Blend
BL Blend 1
BPC-157 / TB-500 / GHK-Cu / KPV
Four-component peptide blend: KPV (Lys-Pro-Val tripeptide), BPC-157 (15-residue gastric pentadecapeptide), GHK-Cu (tripeptide-copper complex), and TB-500 (43-residue thymosin β4 fragment). Single-vial lyophilized preparation.

View Studies →

KPV

Tripeptide
KPV
Lys-Pro-Val · α-MSH Fragment
Tripeptide corresponding to the C-terminal sequence (residues 11–13) of α-melanocyte-stimulating hormone. Sequence H-Lys-Pro-Val-OH. C₁₆H₃₀N₄O₄, MW 342.44, CAS 67727-97-3.

View Studies →

Our Standards

Sourcing
and standards.

Every compound is listed with peer-reviewed references to the primary literature describing the molecule. Our standards prioritize chemistry-first descriptions and accurate sourcing disclosure.

Cold storage
All compounds are held at −20°C from arrival through dispatch. Recommended storage and reconstitution conditions are listed on every product page.

Peer-reviewed references
Every product page includes bibliographic references to primary literature describing the compound. Links go directly to PubMed entries — no summaries, no editorial commentary.

Supplier category
Biovexia LLC is a research chemical supplier. We do not compound, dispense, or prescribe. Our products are sold as research compounds for in-vitro laboratory use.

Research use framework
Every product page, order confirmation, and site footer carries consistent research-use notices. The framework is applied uniformly across the site — at the gate, at checkout, and at the product level.

Standard dispatch
Orders are processed in the order they are received. The standard dispatch window is communicated at order confirmation.

Catalog
The catalog currently contains seventeen research compounds. New additions are listed with supporting bibliographic references as they become available.

17
Research Compounds

≥99%
Purity Standard

−20°C
Storage Standard

PubMed
Reference Source

Bibliographic References

Every product linked
to primary literature.

Every product page includes bibliographic references to the primary literature describing the compound. Links go directly to PubMed entries.


Catalog Updates

New compound releases.

New compound releases, batch availability, and catalog updates.


No spam. Unsubscribe anytime.

RESEARCH USE ONLY: All products are sold exclusively for in-vitro laboratory research use. Not for human, clinical, diagnostic, or therapeutic use. Biovexia Labs is a research chemical supplier and does not compound, dispense, or prescribe.

Scroll to Top